Pfizer’s decision to defer drug price increases could ripple through the drug supply chain, which benefits when drug prices go up.
WSJ.com: Heard on the Street, Wall Street Journal: Markets: Heard on the Street
Wed, 07/11/2018 - 1:11pm
Pfizer’s decision to defer drug price increases could ripple through the drug supply chain, which benefits when drug prices go up.